Cervical microbiota associated with higher grade cervical intraepithelial neoplasia in women infected with high-risk human papillomaviruses

Cancer Prevention Research

Volumn 9, Issue 5, 2016, Pages 357-366

  Piyathilake, Chandrika J ^a   Ollberding, Nicholas J ^b   Kumar, Ranjit ^a   Macaluso, Maurizio ^b   Alvarez, Ronald D ^c   Morrow, Casey D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; FEMALE; GENE AMPLIFICATION; GENOME; HIGH RISK PATIENT; HUMAN; LACTOBACILLACEAE; LACTOBACILLUS; LACTOBACILLUS REUTERI; MAJOR CLINICAL STUDY; MICROFLORA; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX MUCUS; WART VIRUS; ANALOGS AND DERIVATIVES; CANCER GRADING; COMPLICATION; MICROBIOLOGY; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DEOXYGUANOSINE; FEMALE; HUMANS; MICROBIOTA; MIDDLE AGED; NEOPLASM GRADING; OXIDATIVE STRESS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84969963520     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0350     Document Type: Article

References (82)

1. Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 2015;6:6528.
2. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012;21:504-16.
3. Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis 2014;35:249-55.
4. Yu Y, Champer J, Beynet D, Kim J, Friedman AJ. The role of the cutaneous microbiome in skin cancer: lessons learned from the gut. J Drugs Dermatol 2015;14:461-5.
5. Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E, et al. Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci USA 2012;109:E1820-9.
6. Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis 2014;35:249-55.
7. Kuss SK, Best GT, Etheredge CA, Pruijssers AJ, Frierson JM, Hooper LV, et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011;334:249-52.
8. Kane M, Case LK, Kopaskie K, Kozlova A, MacDearmid C, Chervonsky AV, et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science 2011;334:245-9.
9. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353: 1899-911.
10. Watts DH, Fazzari M, MinkoffH, Hillier SL, Sha B, GlesbyM, et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005;191:1129-39.
11. King CC, Jamieson DJ, Wiener J, Cu-Uvin S, Klein RS, Rompalo AM, et al. Bacterial vaginosis and the natural history of human papillomavirus. Infect Dis Obstet Gynecol 2011;2011:319460.
12. Gao W, Weng J, Gao Y, Chen X. Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study. BMC Infect Dis 2013;13:271.
13. Lee JE, Lee S, Lee H, Song YM, Lee K, Han MJ, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLOS ONE 2013;8:e63514.
14. Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, et al. Interplay Between the Temporal Dynamics of the Vaginal Microbiota and Human Papillomavirus Detection. J Infect Dis 2014;210:1723-33.
15. Kumar R, Eipers P, Little RB, Crowley M, Crossman DK, Lefkowitz EJ, et al. Getting started with microbiome analysis: sample acquisition to bioinformatics. Curr Protoc Hum Genet 2014;82:18.8.1-18.8.29.
16. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on theMiSeq Illumina sequencing platform. Appl Environ Microbiol 2013;79:5112-20.
17. Lozupone CA, Hamady M, Kelley ST, Knight R. Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol 2007;73:1576-85.
18. Navas-Molina JA, Peralta-Sanchez JM, Gonzalez A, McMurdie PJ, Vazquez-Baeza Y, Xu Z, et al. Advancing our understanding of the human microbiome using QIIME. Methods Enzymol 2013;531:371-444.
19. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics (Oxford, England) 2010;26:2460-61.
20. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res 2014;42 (Database issue):D633-42.
21. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012;6:610-18.
22. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007;73:5261-7.
23. Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI, Knight R, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nature Methods 2013;10:57-9.
24. Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics (Oxford, England) 2010;26:266-7.
25. Price MN, Dehal PS, Arkin AP. FastTree 2-approximately maximumlikelihood trees for large alignments. PloS one 2010;5:e9490.
26. Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evolution 2009;26:1641-50.
27. Lozupone C, Hamady M, Knight R. UniFrac-an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 2006;7:371.
28. Vazquez-Baeza Y, Pirrung M, Gonzalez A, Knight R. EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience 2013;2:16.
29. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature Biotechnol 2013;31:814-21.
30. Oksanen Jari, Guillaume Blanchet F, Kindt Roeland, Legendre Pierre, Minchin Peter R, O'Hara R B, et al. (2015). vegan: Community Ecology Package. R package version 2.3-0. http://CRAN.R-project. org/package=vegan
31. Holmes I, Harris K, Quince C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS One 2012;7:e30126.
32. Schloss PD, Westcott SL, Ryabin T, Hall JR, HartmannM, Hollister EB, et al. Introducing mothur: open-source, platform-independent, communitysupported software for describing and comparingmicrobial communities. Appl Environ Microbiol 2009;75:7537-41.
33. Hayes A.Introduction to Mediation, Moderation and conditional process analysis. Chapter 4. New York, NY: The Guilford Press; 2013.
34. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60.
35. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014;15:550.
36. Brotman RM. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest 2011;121:4610-17.
37. Anahtar MN, Byrne EH, Doherty KE, Bowman BA, Yamamoto HS, Soumillon M, et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 2015;42, 965-76.
38. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a lowbirth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-42.
39. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003;189:139-47.
40. Wilks M, Wiggins R, Whiley A, Hennessy E, Warwick S, Porter H, et al. Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol 2004;42:713-7.
41. Oh HY, Kim BS, Seo SS, Kong JS, Lee JK, Park SY, et al. The association of uterine cervical microbiotawith an increased risk for cervical intraepithelial neoplasia in Korea. Clin Microbiol Infect 2015;21:674.e1-9.
42. Smith BC, McAndrew T, Chen Z, Harari A, Barris DM, Viswanathan S, et al. The cervical microbiome over 7 years and a comparison of methodologies for its characterization. PLoS ONE 2012;7:e40425.
43. Falsen E, Pascual C, Sjoden B, Ohlen M, Collins MD. Phenotypic and phylogenetic characterization of a novel Lactobacillus species from human sources: description of Lactobacillus iners sp. nov. Int J Syst Bacteriol 1999; 49:217-21.
44. Witkin SS, Mendes-Soares H, Linhares IM, Jayaram A, LedgerWJ, Forney LJ. Influence of vaginal bacteria and D-and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. MBio. 2013;4:e00460-13.
45. Schirmer M, Ijaz UZ, D'Amore R, Hall N, Sloan WT, Quince C. Schirmer. Insight into biases and sequencing errors for amplicon sequencingwith the Illumina MiSeq platform. Nucleic Acids Research 2015;43:e37.
46. Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WK, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun 2015;6:8727.
47. UchihashiM, Bergin I, Bassis C, Hashway S, Chai D, Bell J. Influence of age, reproductive cycling status, and menstruation on the vaginal microbiome in baboons (Papio anubis). Am J Primatol 2015;77:563-578.
48. Yooseph S, Kirkness EF, Tran TM, Harkins DM, Jones MB, Torralba MG, et al. Stool microbiota composition is associated with the prospective risk of Plasmodium falciparum infection. Bmc Genomics 2015;16:631.
49. Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut Microotia 2016;65: 57-62.
50. Martin Morgan. DirichletMultinomial: Dirichlet-multinomial mixture model machine learning for microbiome data. R package version 1.12.1.
51. Ding T, Schloss PD. Dynamics and associations of microbial community types across the human body. Nature 2014;509:357-360.
52. Lakritz JR, Poutahidis T, Levkovich T, Varian BJ, Ibrahim YM, Chatzigiagkos A, et al. Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition tomammary cancer in mice. Int J Cancer 2014;135:529-40.
53. Szajewska H, Gyrczuk E, Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2013;162:257-62.
54. Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 2013;66:462-70.
55. Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007;20:593-621.
56. Jalanka-Tuovinen J, Salonen A, Nikkilä J, Immonen O, Kekkonen R, Lahti L, et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One 2011;6:e23035.
57. Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009;11:2574-84.
58. Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog. 2013;5:23.
59. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013; 13:800-12.
60. Gillet E, Meys JF, Verstraelen H, Bosire C, De Sutter P, Temmerman M, et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect Dis 2011; 11:10.
61. Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 2005;192:394-8.
62. El Aila NA, Tency I, Claeys G, Verstraelen H, Saerens B, Santiago GL, et al. Identification and genotyping of bacteria from paired vaginal and rectal samples from pregnant women indicates similarity between vaginal and rectal microflora. BMC Infect Dis 2009;9:167.
63. Petricevic L, Domig KJ, Nierscher FJ, Krondorfer I, Janitschek C, Kneifel W, et al. Characterisation of the oral, vaginal and rectal Lactobacillus flora in healthy pregnant and postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2012;160:93-9.
64. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995;358:1-3.
65. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 1996;32A:1209-14.
66. Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, et al. Increased formation of oxidative DNA damage, 8-hydroxy-20-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 2000;151:87-95.
67. Oliva MR, Ripoll F, Mu~niz P, Iradi A, Trullenque R, Valls V, et al. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinog. 1997;18:232-43.
68. Romano G, Sgambato A, Mancini R, Capelli G, Giovagnoli MR, Flamini G, et al. 8-Hydroxy-2-deoxyguanosine in cervical cells: correlation with grade of dysplasia and human papillomavirus infection. Carcinogenesis 2000;21:1143-7.
69. Visalli G, Riso R, Facciola A, Mondello P, Caruso C, Picerno I, et al. Higher levels of oxidative DNA damage in cervical cells are correlated with the grade of dysplasia and HPV infection. J Med Virol 2016;88:336-44.
70. Neish AS. Redox signalingmediated by the gutmicrobiota. Free Radical Res 2013;47:950-7.
71. Garrett WS. Cancer and the microbiota. Science. 2015;348:80-6.
72. Zhang X, WuRS, Fu W, Xu L, Lam PK. Production of reactive oxygen species and 8-hydroxy-2'deoxyguanosine in KB cells co-exposed to benzoa]pyrene and UV-A radiation. Chemosphere 2004;55:1303-8.
73. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661-72.
74. Gray LR, Tompkins SC, Taylor EB. Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci 2014;71:2577-604.
75. Andergassen U, Liesche F, Kolbl AC, Ilmer M, Hutter S, Friese K, Jeschke U. Glycosyltransferases as markers for early tumorigenesis. Biomed Res Int 2015;2015:792672.
76. Piyathilake CJ, Macaluso M, Alvarez RD, Chen M, Badiga S, Siddiqui NR, et al. A higher degree of LINE-1 methylation in peripheral blood mononuclear cells, a one-carbon nutrient related epigenetic alteration, is associated with a lower risk of developing cervical intraepithelial neoplasia. Nutrition 2011;27:513-9.
77. Hill MJ. Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev 1997;6:S43-5.
78. Rossi M, Amaretti A, Raimondi S. Folate production by probiotic bacteria. Nutrients 2011;3:118-34.
79. Magnusdottir S, Ravcheev D, de Crecy-Lagard V, Thiele I. Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet 2015;6:148.
80. Crott JW, Liu Z, Keyes MK, Choi SW, Jang H, Moyer MP, et al. Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. J Nutr Biochem 2008;19:328-35.
81. Wu M, Gunning W, Ratnam M. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 1999;8:775-82.
82. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007;28:739-45.